These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 3316494)

  • 1. Neuropathological substrates of Alzheimer's disease and Parkinson's disease.
    Jellinger K
    J Neural Transm Suppl; 1987; 24():109-29. PubMed ID: 3316494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in the pathology of Parkinson's disease.
    Jellinger K
    Adv Neurol; 1990; 53():1-16. PubMed ID: 1978509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
    Papapetropoulos S; Lieberman A; Gonzalez J; Mash DC
    Acta Neurol Scand; 2005 Jun; 111(6):353-9. PubMed ID: 15876335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease.
    Yoshimura M
    Eur Neurol; 1988; 28 Suppl 1():29-35. PubMed ID: 3378559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid beta-peptide and the dementia of Parkinson's disease.
    Jendroska K; Lees AJ; Poewe W; Daniel SE
    Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The morphological basis of mental dysfunction in Parkinson's disease.
    Jellinger KA
    J Neurol Sci; 2006 Oct; 248(1-2):167-72. PubMed ID: 16797594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
    Farlow MR; Cummings J
    Dement Geriatr Cogn Disord; 2008; 25(4):301-8. PubMed ID: 18311077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
    Rinne JO; Rummukainen J; Paljärvi L; Säkö E; Mölsä P; Rinne UK
    Prog Clin Biol Res; 1989; 317():325-32. PubMed ID: 2602422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):223-46. PubMed ID: 7699112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.
    Joachim CL; Morris JH; Selkoe DJ
    Ann Neurol; 1988 Jul; 24(1):50-6. PubMed ID: 3415200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewy bodies and progressive dementia: a critical review and meta-analysis.
    Cercy SP; Bylsma FW
    J Int Neuropsychol Soc; 1997 Mar; 3(2):179-94. PubMed ID: 9126859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):189-222. PubMed ID: 7535318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
    Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
    Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of degenerative neurological disease.
    Cork LC; Kitt CA; Struble RG; Griffin JW; Price DL
    Prog Clin Biol Res; 1987; 229():241-69. PubMed ID: 3601987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical Lewy bodies in Alzheimer's disease.
    Kazee AM; Han LY
    Arch Pathol Lab Med; 1995 May; 119(5):448-53. PubMed ID: 7748074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease.
    Janvin CC; Larsen JP; Salmon DP; Galasko D; Hugdahl K; Aarsland D
    Mov Disord; 2006 Mar; 21(3):337-42. PubMed ID: 16211595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
    Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.